PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

Not only that, it is a common practice of most small biotech's.

This practice is a turn off for big investors who wait for major milestones to be accomplished before investing, like promising human trial endpoints, when the price gets out reach for most retail investors.

However, at under a dime a share, it is a great opportunity for small investors who see the potential in this revolutionary technology, Cell in a Box(R). That is one of the reasons I accept the risks with the upside potential here. I think Dr Von Hoff will take Cell in a Box(R) to market for oncology and we just may cure type 1 diabetes without the need for immunosuppressants.

http://www.pharmacytebiotech.com/media/